Supplementary Implants Supporting Conventional Removable Dental Prosthesis (RDPs) in Kennedy Class I
Supplementary Implants Supporting Conventional RDPs in Kennedy Class I: A Dual-centered Randomized Controlled Trial
University Hospital, Basel, Switzerland
12 participants
Feb 6, 2020
INTERVENTIONAL
Conditions
Summary
In this study the additional effect of supplementary implants in patients with Kennedy Class I in terms of patient-reported outcome measures (PROMs) and cost-benefit-analyses comparing costs of maintenance care will be investigated
Eligibility
Inclusion Criteria4
- Subjects must have voluntarily signed the informed consent before any study action, are willing and able to attend scheduled follow-up visits, and agree that the encoded data will be collected and analyzed
- Males and females with at least 18 years of age
- intraoral situation with bilateral edentulous areas located posterior to the remaining natural teeth (Kennedy class I) in the upper or lower jaw
- remaining dentition includes a first premolar, canine or incisor as the most posterior tooth
Exclusion Criteria7
- Uncontrolled systemic disease that would interfere with dental implant therapy;
- Patients who smoke \> 10 cigarettes per day or tobacco equivalents;
- Patients with alcohol and/or drug abuse;
- Patients with chronic pain;
- Patients with untreated periodontitis and / or inadequate oral hygiene (Plaque Index \< 30%);
- Medical conditions requiring chronic high dose steroid therapy or anti-resorptive treatment;
- Conditions or circumstances, in the opinion of the investigators, which would prevent completion of study participation or interfere with analysis of study results such as history of non-compliance or unreliability.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
retentive components (Group A Test), which are connected to the implants to retain the RPD
supportive components (Group B Control), which are connected to the implants to support the RPD
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04276246